MIH
GILD icon

Meitav Investment House’s Gilead Sciences GILD Stock Holding History

Meitav Investment House’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,409
Closed -$336K – 409
2023
Q2 		$336K Buy
4,409
+1,348
+44% +$108K 0.01% 307
2023
Q1 		$250K Sell
3,061
-1,498
-33% -$124K ﹤0.01% 332
2022
Q4 		$389K Hold
4,559
– – 0.01% 305
2022
Q3 		$287K Buy
+4,559
New +$287K 0.01% 325
2022
Q1 		– Sell
-4,061
Closed -$297K – 393
2021
Q4 		$297K Sell
4,061
-4,500
-53% -$310K ﹤0.01% 345
2021
Q3 		$603K Sell
8,561
-500
-6% -$35.1K 0.01% 295
2021
Q2 		$619K Buy
9,061
+5,000
+123% +$334K 0.02% 288
2021
Q1 		$263 Sell
4,061
-2,200
-35% -$142K 0.01% 334
2020
Q4 		$361K Sell
6,261
-3,200
-34% -$193K 0.01% 319
2020
Q3 		$593K Buy
9,461
+3,000
+46% +$208K 0.03% 234
2020
Q2 		$491K Sell
6,461
-8,849
-58% -$678K 0.03% 227
2020
Q1 		$1.15M Buy
15,310
+9,960
+186% +$688K 0.09% 128
2019
Q4 		$348K Sell
5,350
-90
-2% -$5.86K 0.03% 295
2019
Q3 		$348K Hold
5,440
– – 0.03% 298
2019
Q2 		$364K Sell
5,440
-2,450
-31% -$161K 0.02% 302
2019
Q1 		$506K Buy
7,890
+293
+4% +$19.5K 0.03% 238
2018
Q4 		$453K Sell
7,597
-533
-7% -$37.3K 0.03% 211
2018
Q3 		$621K Sell
8,130
-3,479
-30% -$263K 0.03% 268
2018
Q2 		$998K Sell
11,609
-874
-7% -$61.7K 0.04% 204
2018
Q1 		$939K Buy
12,483
+2,743
+28% +$218K 0.05% 171
2017
Q4 		$704K Buy
+9,740
New +$740K 0.04% 143

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Meitav Investment House's GILD Position: Q3 2023 in Review

Meitav Investment House sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 4,409 shares — an estimated $336K sold.

Meitav Investment House first reported a position in GILD in Q4 2017 and held it in 21 quarters. The position peaked at $1.15M in Q1 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Meitav Investment House reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Meitav Investment House sold 4,409 Gilead Sciences shares in Q3 2023, an estimated $336K.
  • Meitav Investment House first reported a position in Gilead Sciences in Q4 2017 and held it in 21 quarters.
  • Meitav Investment House's Gilead Sciences position peaked at $1.15M in Q1 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Meitav Investment House's 13F filing for Q3 2023, filed 30 Oct 2023.